Article Data

  • Views 169
  • Dowloads 149

This is a correction to: European Journal of Gynaecological Oncology. 2025; 46(10): 5-13. https://doi.org/10.22514/ejgo.2025.126

Corrections

Open Access

Correction: The role of progesterone in ovarian cancer from pathogenesis to personalized therapy: an updated mini-review

  • Iara Fernandes1,†
  • Rita Coelho2,*,†,
  • Margarida Figueiredo-Dias1
  • Ricardo Roque2

1Faculty of Medicine, Gynecology University Clinic, University of Coimbra, 3000-548 Coimbra, Portugal

2Medical Oncology Department, Portuguese Institute of Oncology of Coimbra, 3000-075 Coimbra, Portugal

DOI: 10.22514/ejgo.2026.061 Vol.47,Issue 3,October 2026 pp.165-165

Published: 15 October 2026

*Corresponding Author(s): Rita Coelho E-mail: 4126@ipocoimbra.min-saude.pt

† These authors contributed equally.

PDF (242.94 kB) View Full-text

Cite and Share

Iara Fernandes, Rita Coelho, Margarida Figueiredo-dias, Ricardo Roque. Correction: The role of progesterone in ovarian cancer from pathogenesis to personalized therapy: an updated mini-review. European Journal of Gynaecological Oncology. 2026; 47(3): 165-165. doi: 10.22514/ejgo.2026.061

References

[1] Fernandes I, Coelho R, Figueiredo-Dias M, Roque R. The role of progesterone in ovarian cancer from pathogenesis to personalized therapy: an updated mini-review. European Journal of Gynaecological Oncology. 2025; 46: 5–13.

Submission Turnaround Time

Top